Related Experiment Video
Updated: Mar 31, 2026
08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
5.1K
Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
Amandine Grimm1,2, Kristina Friedland3, Anne Eckert4,5
1Neurobiology Laboratory for Brain Aging and Mental Health, Transfaculty Research Platform, Molecular & Cognitive Neuroscience, University of Basel, Wilhelm Klein-Str. 27, 4012, Basel, Switzerland.
Biogerontology
|October 16, 2015
Summary
Mitochondrial dysfunction links normal aging to Alzheimer's disease (AD). This review explores how mitochondrial deregulation and metabolic changes contribute to neurodegeneration, offering potential therapeutic targets for AD.
Area of Science:
- Neuroscience
- Gerontology
- Biochemistry
Background:
- Alzheimer's disease (AD) is a leading cause of dementia in the elderly, with aging as the primary risk factor.
- Current research often models AD using rare familial cases, potentially overlooking mechanisms of late-onset AD.
- Both normal aging and AD share hallmarks of impaired brain metabolism and oxidative stress.
Purpose of the Study:
- To compare commonalities between brain aging and AD.
- To center the role of mitochondria in distinguishing normal aging from pathological aging.
- To present a bioenergetic model for AD pathogenesis.
Main Methods:
- Review of existing literature on brain aging and Alzheimer's disease.
- Comparative analysis of mitochondrial roles in aging and AD.
- Emphasis on bioenergetic deficits and metabolic reprogramming in AD.
Main Results:
- Mitochondria are central to cellular bioenergetics and redox homeostasis, implicating them in both aging and AD.
- Late-onset AD pathogenesis may stem from age-related mitochondrial malfunction, distinct from familial AD genetic causes.
- The inverse Warburg hypothesis suggests AD involves mitochondrial deregulation and metabolic reprogramming.
Conclusions:
- Mitochondrial dysfunction is a key factor connecting aging and sporadic Alzheimer's disease.
- Metabolic reprogramming, initially compensatory, can ultimately lead to neuronal death in AD.
- Targeting mitochondrial pathways offers promising therapeutic strategies for neurodegeneration.
Related Concept Videos
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:37Mitochondria
21.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.4K
01:45Mitochondrial Membranes
17.8K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.8K
01:48ATP Synthase: Mechanism
18.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.8K
03:03Amyloid Fibrils
13.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.0K